Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma

NCT05173610 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Oligometastasis Hepatocellular Carcinoma

Interventions

RADIATION: Radiation: Stereotactic body radiotherapy (SBRT)

Sponsor

Yonsei University